Christopher S. Holland - 08 Aug 2025 Form 4 Insider Report for STERIS plc (STE)

Reporting relationship: Director
Issuer ticker: STE
Reported as of: 08 Aug 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Aug 2025, 17:26:20 UTC
Prior SEC filing: 26 Mar 2025
Next SEC filing: 26 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ John P. Ubbing, Authorized Representative under Power of Attorney

Key filing fact

Christopher S. Holland filed Form 4 for STERIS plc (STE) on 12 Aug 2025.

Key facts

This page summarizes Christopher S. Holland's Form 4 filing for STERIS plc (STE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 12 Aug 2025, 17:26.

Change

Previous filing in this sequence was filed on 26 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001271440 Primary reporting owner

HOLLAND CHRISTOPHER S

Relationship: Director
Address: C/O 70 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, IRELAND
Signature: /s/ John P. Ubbing, Authorized Representative under Power of Attorney
Signature date: 12 Aug 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STE transaction Derivative

Career Restricted Stock Units

Award

Transaction value: $0
Shares: +975
Change %: +24%
Price: $0.000000
Shares after: 4,964
Date: 08 Aug 2025
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 975
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.

Footnote F2

These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.